Search Results - "Shul'ginova, A A"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    PHARMACOLOGICAL CORRECTION OF RED BLOOD CELL MEMBRANE LIPID SPECTRUM IN PATIENTS WITH CHRONIC CEREBRAL ISCHEMIA ON THE BACKGROUND OF HYPERTENSIVE DISEASE. by Shul'ginova, A A, Laskov, V B, Konoplya, A I, Karaulov, A V

    “…In patients with chronic cerebral ischemia on the background of hypertension grade 2, stage 2, our investigation revealed a significant decrease (by 30.1%) in…”
    Get more information
    Journal Article
  2. 2

    Immune and oxygen disturbances in patients with chronic cerebral ischemia and their correction by Konoplya, A I, Laskov, V B, Shul'ginova, A A

    “…To determine the dynamics of immunometabolic characteristics in patients with chronic ischemia of the brain (discirculatory encephalopathy - DE) under the…”
    Get more information
    Journal Article
  3. 3

    CORRELATION ANALYSIS BETWEEN LABORATORY IMMUNE AND METABOLIC PARAMETERS IN CHRONIC BRAIN ISCHEMIA STAGES I AND II ALONG WITH HYPERTENSION AFTER TREATMENT by Bystrova, N. A., Shulginova, A. A., Konoplya, A. I.

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (19-10-2021)
    “…Determination of interrelationships between impairments of laboratory parameters of immune and metabolic status in patients with chronic cerebral ischemia of…”
    Get full text
    Journal Article
  4. 4

    PERSONALIZED PHARMACOLOGICAL CORRECTION OF IMMUNE SYSTEMS, METABOLIC AND NEUROPSYCHIC PARAMETERS IN CHRONIC BRAIN ISCHEMIA OF STAGE I AND II ON THE BACKGROUND OF HYPERTENSION DISEASE by Konoplya, A. I., Shulginova, A. A., Bystrova, N. A., Gavrilyuk, V. P., Ryzhikova, G. N.

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (19-10-2021)
    “…The study aimed to develop a personalized pharmacological correction of immune, metabolic and neuropsychiatric disorders in chronic cerebral ischemia (CCI)…”
    Get full text
    Journal Article
  5. 5

    Proteins of allogeneic hepatocytes and pharmacological preparations for the correction of immunometabolic disorders in experimental liver pathology by Litvinova, Ekaterina S., Konoplya, Nikolay N., Shulginova, Anastasiya A., Kharchenko, Anastasiya V.

    “…Introduction: The relationship of numerous metabolic shifts, disorders of hepatocytes functional activity resulting from hypoxia and toxic liver damage with…”
    Get full text
    Journal Article
  6. 6

    CORRECTION OF IMMUNE DISTURBANCES IN CHRONIC CEREBRAL ISCHEMIA by Shulginova, A. A., Konoplya, A. I., Bystrova, N. A., Gavriliuk, V. P., Karaulov, A. V.

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (10-06-2018)
    “…The aim of the study was to determine efficiency of Glutoxim, aimed for correction of immune disorders. The drug was administered to the patients with chronic…”
    Get full text
    Journal Article
  7. 7

    Disorders of the immune status in patients with chronic cerebral ischemia; differentiated pharmacological correction by Shulginova, Anastasiya A., Konoplya, Alexander I., Bystrova, Natalya A.

    “…Introduction: Chronic cerebral ischemia (CCI) accounts for 60-75% of all cerebrovascular diseases in Russia and around the world. The problem: the issues…”
    Get full text
    Journal Article
  8. 8

    CORRECTION OF IMMUNE DISTURBANCES IN CHRONIC CEREBRAL ISCHEMIA by Shulginova, A A, Konoplya, A I, Bystrova, N A, Gavriliuk, V P, Karaulov, A V

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (01-01-2018)
    “…The aim of the study was to determine efficiency of Glutoxim, aimed for correction of immune disorders. The drug was administered to the patients with chronic…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12